• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Equitable access to cell and gene therapies in South Africa: opportunities and hurdles.

作者信息

Hendricks Candice Laverne, Alessandrini Marco, Pepper Michael Sean

机构信息

Institute for Cellular and Molecular Medicine, Department of Immunology, and South African Medical Research Council Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Antion Biosciences SA, Geneva, Switzerland.

出版信息

Gene Ther. 2023 Feb;30(1-2):180-186. doi: 10.1038/s41434-021-00309-y. Epub 2022 Jan 8.

DOI:10.1038/s41434-021-00309-y
PMID:34997201
Abstract
摘要

相似文献

1
Equitable access to cell and gene therapies in South Africa: opportunities and hurdles.南非细胞和基因疗法的公平获取：机遇与障碍。
Gene Ther. 2023 Feb;30(1-2):180-186. doi: 10.1038/s41434-021-00309-y. Epub 2022 Jan 8.
2
The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa.科学家联盟关于在南非公平、及时获取新冠疫苗的十点提议。
S Afr Med J. 2020 Dec 14;111(2):89-94. doi: 10.7196/SAMJ.2021.v111i2.15498.
3
Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?非洲的药品获取与丙型肝炎：分级定价和自愿许可能否确保普遍获取、健康公平与公正？
Global Health. 2017 Sep 13;13(1):73. doi: 10.1186/s12992-017-0297-6.
4
Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India.基因治疗的可及性：来自巴西、南非和印度的全球挑战、机遇和观点。
Mol Ther. 2022 Jun 1;30(6):2122-2129. doi: 10.1016/j.ymthe.2022.04.002. Epub 2022 Apr 4.
5
Prioritising and mapping barriers to achieve equitable surgical care in South Africa: a multi-disciplinary stakeholder workshop.优先考虑和绘制障碍图以实现南非公平的手术护理：多学科利益相关者研讨会。
Glob Health Action. 2022 Dec 31;15(1):2067395. doi: 10.1080/16549716.2022.2067395.
6
Why equity in health and in access to health care are elusive: Insights from Canada and South Africa.卫生和医疗保健公平难以实现的原因：来自加拿大和南非的见解。
Glob Public Health. 2018 Nov;13(11):1533-1557. doi: 10.1080/17441692.2017.1407813. Epub 2017 Dec 4.
7
The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa.科学家联盟关于在南非公平、及时获取新冠疫苗的十点提议。
S Afr Med J. 2020 Dec 14;0(0):13163.
8
Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities.确保美国公平获得 COVID-19 疫苗：当前系统面临的挑战和机遇。
Health Aff (Millwood). 2021 Jan;40(1):62-69. doi: 10.1377/hlthaff.2020.01554. Epub 2020 Nov 19.
9
Cell and gene therapies at the forefront of innovative medical care: Implications for South Africa.细胞和基因疗法引领创新医疗：对南非的影响。
S Afr Med J. 2018 Dec 13;109(1):20-22. doi: 10.7196/SAMJ.2018.v109i1.13425.
10
Equitable distribution of PEPFAR-supported HIV/AIDS services in South Africa.南非抗逆转录病毒治疗援助项目（PEPFAR）所支持的艾滋病毒/艾滋病服务的公平分配。
Am J Public Health. 2011 Aug;101(8):1349-51; author reply 1351. doi: 10.2105/AJPH.2011.300242. Epub 2011 Jun 16.

引用本文的文献

1
How to democratize cell and gene therapy: A global approach.如何使细胞和基因疗法民主化：一种全球方法。
Mol Ther. 2025 May 7;33(5):2082-2090. doi: 10.1016/j.ymthe.2025.03.061. Epub 2025 Apr 2.
2
Navigating equity in global access to genome therapy expanding access to potentially transformative therapies and benefiting those in need requires global policy changes.在全球范围内实现基因治疗的公平可及性——扩大获得潜在变革性疗法的机会并造福有需要的人，需要全球政策变革。
Front Genet. 2024 Apr 4;15:1381172. doi: 10.3389/fgene.2024.1381172. eCollection 2024.
3
Nurses' roles in CAR-T therapy for B-cell malignancies and managing associated cytokine release syndrome.

本文引用的文献

1
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.腺苷脱氨酶缺乏症的自体体外慢病毒基因治疗。
N Engl J Med. 2021 May 27;384(21):2002-2013. doi: 10.1056/NEJMoa2027675. Epub 2021 May 11.
2
Perspectives on establishing a public cord blood inventory in South Africa.南非建立公共脐带血库的观点。
Cytotherapy. 2021 Jun;23(6):548-557. doi: 10.1016/j.jcyt.2021.02.116. Epub 2021 Apr 6.
3
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.伊达比星脂质体注射用多柔比星治疗复发/难治性多发性骨髓瘤
护士在B细胞恶性肿瘤的CAR-T治疗及相关细胞因子释放综合征管理中的作用。
Asia Pac J Oncol Nurs. 2023 Dec 28;11(2):100367. doi: 10.1016/j.apjon.2023.100367. eCollection 2024 Feb.
4
Looking ahead: ethical and social challenges of somatic gene therapy for sickle cell disease in Africa.展望未来：非洲镰状细胞病体细胞基因治疗的伦理和社会挑战。
Gene Ther. 2024 May;31(5-6):202-208. doi: 10.1038/s41434-023-00429-7. Epub 2023 Nov 27.
5
Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India.基因治疗的可及性：来自巴西、南非和印度的全球挑战、机遇和观点。
Mol Ther. 2022 Jun 1;30(6):2122-2129. doi: 10.1016/j.ymthe.2022.04.002. Epub 2022 Apr 4.
N Engl J Med. 2021 Feb 25;384(8):705-716. doi: 10.1056/NEJMoa2024850.
4
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table.迈向血友病基因治疗全球多学科共识框架：第二届世界血友病基因治疗圆桌会议报告。
Haemophilia. 2020 May;26(3):443-449. doi: 10.1111/hae.13971. Epub 2020 Mar 23.
5
Socio-economic inequalities in the multiple dimensions of access to healthcare: the case of South Africa.社会经济不平等与医疗保健多维度获取之间的关系：以南非为例。
BMC Public Health. 2020 Mar 4;20(1):289. doi: 10.1186/s12889-020-8368-7.
6
Estimating a cost-effectiveness threshold for health care decision-making in South Africa.估算南非医疗保健决策的成本效益阈值。
Health Policy Plan. 2020 Jun 1;35(5):546-555. doi: 10.1093/heapol/czz152.
7
'Off-the-shelf' allogeneic CAR T cells: development and challenges.现成的异体嵌合抗原受体 T 细胞：开发与挑战。
Nat Rev Drug Discov. 2020 Mar;19(3):185-199. doi: 10.1038/s41573-019-0051-2. Epub 2020 Jan 3.
8
Cut-price CAR-T cell therapies top India's biotech agenda.低价嵌合抗原受体T细胞疗法成为印度生物技术领域的首要议程。
Nat Biotechnol. 2019 Dec;37(12):1388-1389. doi: 10.1038/s41587-019-0346-1.
9
Therapeutic genome engineering: Implications for South Africa.治疗性基因组工程：对南非的影响。
S Afr Med J. 2019 Sep 10;109(8b):53-57. doi: 10.7196/SAMJ.2019.v109i8b.13850.
10
Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation.创新的β地中海贫血治疗方法：基因治疗与异体造血干细胞移植的成本效益分析。
Hum Gene Ther. 2019 Jun;30(6):753-761. doi: 10.1089/hum.2018.178. Epub 2019 May 3.